COST-EFFECTIVENESS OF VARENICLINE VERSUS EXISTING SMOKING CESSATION STRATEGIES IN BRAZIL FROM THE PUBLIC PERSPECTIVE, USING THE BENESCO MODEL

被引：0
|
作者：
Fujii, R. [1 ]
Correia, E. A. [1 ]
Mould, J. F. [2 ]
机构：
[1] Pfizer Pharmaceut Inc, Sao Paulo, Brazil
[2] Pfizer Inc, New York, NY USA
来源：
VALUE IN HEALTH | 2011年 / 14卷 / 07期
关键词：
D O I：
10.1016/j.jval.2011.08.1388
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A487 / A487
页数：1
相关论文
共 50 条
  • [31] Developing a Cost-Effectiveness Model of Digital Therapeutics for Smoking Cessation
    Yoo, Sung Goo
    Kim, Dai Jin
    Chun, Ji Won
    Choi, In Young
    MEDINFO 2023 - THE FUTURE IS ACCESSIBLE, 2024, 310 : 1548 - 1549
  • [32] What is the clinical effectiveness and cost-effectiveness of cytisine compared with varenicline for smoking cessation? A systematic review and economic evaluation
    Leaviss, Joanna
    Sullivan, William
    Ren, Shijie
    Everson-Hock, Emma
    Stevenson, Matt
    Stevens, John W.
    Strong, Mark
    Cantrell, Anna
    HEALTH TECHNOLOGY ASSESSMENT, 2014, 18 (33) : 1 - +
  • [33] Cost-Effectiveness of Varenicline Versus Bupropion, Nicotine-Replacement Therapy, and Unaided Cessation in Greece
    Athanasakis, Kostas
    Igoumenidis, Michael
    Karampli, Eleftheria
    Vitsou, Elli
    Sykara, Georgia
    Kyriopoulos, John
    CLINICAL THERAPEUTICS, 2012, 34 (08) : 1803 - 1814
  • [34] EXTENDED COST-EFFECTIVENESS ANALYSIS OF VARENICLINE FOR SMOKING CESSATION IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE IN THAILAND
    Prasitwarachot, R.
    Boonmanunt, S.
    Pornsuriyasak, P.
    Thavorn, K.
    Patikorn, C.
    Chaiyakunapruk, N.
    VALUE IN HEALTH, 2023, 26 (06) : S72 - S72
  • [35] EFFECTIVENESS AND COST ANALYSIS OF THE SMOKING CESSATION PROGRAM IN THE PUBLIC HEALTH SYSTEM IN BRAZIL
    Mendes, A. C. R.
    Barcellos, R. M. S.
    Ritzel, J. B.
    Ribeiro, A. P.
    Pereira, N. M.
    Oliveira, V. C.
    Toscano, C. M.
    VALUE IN HEALTH, 2013, 16 (07) : A724 - A724
  • [36] THE COST-EFFECTIVENESS OF AN EXTENDED COURSE (12+12 WEEKS) OF VARENICLINE PLUS BRIEF COUNSELLING COMPARED WITH OTHER REIMBURSED SMOKING CESSATION INTERVENTIONS IN BELGIUM, FROM A PUBLIC PAYER PERSPECTIVE
    Knight, C.
    Marbaix, S.
    Annemans, L.
    Prignot, J.
    Bowrin, K.
    ACTA CLINICA BELGICA, 2012, 67 (06) : 416 - 422
  • [37] The effectiveness, safety and cost-effectiveness of cytisine versus varenicline for smoking cessation in an Australian population: a study protocol for a randomized controlled non-inferiority trial
    Thomas, Dennis
    Farrell, Michael
    McRobbie, Hayden
    Tutka, Piotr
    Petrie, Dennis
    West, Robert
    Siahpush, Mohammad
    Gartner, Coral
    Walker, Natalie
    Mendelsohn, Colin P.
    Hall, Wayne
    Paul, Christine
    Zwar, Nicholas
    Ferguson, Stuart G.
    Boland, Veronica C.
    Richmond, Robyn
    Doran, Christopher M.
    Shakeshaft, Anthony
    Mattick, Richard P.
    Courtney, Ryan J.
    ADDICTION, 2019, 114 (05) : 923 - 933
  • [38] A long term cost-effectiveness analysis model for smoking cessation in Korea
    Bae, J. Y.
    Song, H. J.
    Joe, K. H.
    Kim, C. H.
    Song, H. R.
    Ryu, G. C.
    Kim, D. J.
    Lee, E. K.
    VALUE IN HEALTH, 2008, 11 (03) : A275 - A275
  • [39] A long term cost-effectiveness analysis model for smoking cessation in Mexico
    Mould-Quevedo, J.
    Saenz-Montanez, J.
    Davila-Loaiza, G.
    VALUE IN HEALTH, 2007, 10 (03) : A101 - A101
  • [40] SIMULATING COST-EFFECTIVENESS OF STEPPED CARE VERSUS REPEAT CARE IN SMOKING CESSATION
    Franklin, B. E.
    Klesges, R.
    VALUE IN HEALTH, 2009, 12 (03) : A123 - A123
12345